Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG. (2017)

First Author: Hadji P
Attributed to:  Lifecourse Determinants of Bone and Joint Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jbo.2017.03.001

PubMed Identifier: 28413771

Publication URI: http://europepmc.org/abstract/MED/28413771

Type: Journal Article/Review

Volume: 7

Parent Publication: Journal of bone oncology

ISSN: 2212-1366